Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
作者信息
Brittain Evan L, Hemnes Anna R
机构信息
Vanderbilt University Medical Center, Nashville, TN.
出版信息
Circ Res. 2022 Apr 29;130(9):1362-1364. doi: 10.1161/CIRCRESAHA.122.321168. Epub 2022 Apr 28.
Abstract
摘要
相似文献
1
Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
Circ Res. 2022 Apr 29;130(9):1362-1364. doi: 10.1161/CIRCRESAHA.122.321168. Epub 2022 Apr 28.
2
Chronic Right Heart Failure: Expanding Prevalence and Challenges in Outpatient Management.
Heart Fail Clin. 2018 Jul;14(3):413-423. doi: 10.1016/j.hfc.2018.03.007.
3
The Right Heart-Pulmonary Circulation Unit in Systemic Hypertension.
Heart Fail Clin. 2018 Jul;14(3):247-253. doi: 10.1016/j.hfc.2018.02.002.
4
Right Ventricular to Pulmonary Circulation Coupling Comes to the Front Line in Acute Heart Failure With Preserved Ejection Fraction.
Circ Cardiovasc Imaging. 2020 Nov;13(11):e012001. doi: 10.1161/CIRCIMAGING.120.012001. Epub 2020 Nov 17.
5
Ventricular Assist Device Use in Patients With Single-Ventricle Circulation.
Can J Cardiol. 2022 Jul;38(7):1086-1099. doi: 10.1016/j.cjca.2022.03.012. Epub 2022 Mar 18.
6
The Right Heart-Pulmonary Circulation Unit: Physiopathology.
Heart Fail Clin. 2018 Jul;14(3):237-245. doi: 10.1016/j.hfc.2018.02.001.
7
[Management of right ventricular failure in pulmonary vascular diseases].
Rev Mal Respir. 2020 Feb;37(2):171-179. doi: 10.1016/j.rmr.2019.07.012. Epub 2020 Feb 13.
8
Pulmonary Hypertension and Heart Failure: A Dangerous Liaison.
Heart Fail Clin. 2018 Jul;14(3):297-309. doi: 10.1016/j.hfc.2018.02.006.
9
Role of pulmonary hypertension, hypoxaemia and right ventricular hypertrophy on the right heart failure in pulmonary heart diseases.
Singapore Med J. 1973 Sep;14(3):306-10.
10
Pulmonary vascular and cardiac impairment in interstitial lung disease.
Eur Respir Rev. 2017 Jan 17;26(143). doi: 10.1183/16000617.0053-2016. Print 2017 Jan.
引用本文的文献
1
Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251367312. doi: 10.1177/17534666251367312. Epub 2025 Aug 29.
2
Chronic Mercury Exposure Triggers Vascular Remodeling and Impaired Vasoconstriction in Small Intrapulmonary Arteries.
Cardiovasc Toxicol. 2025 Aug 13. doi: 10.1007/s12012-025-10047-x.
3
Pulmonary vascular disease, environmental pollution, and climate change.
Pulm Circ. 2024 Jun 26;14(2):e12394. doi: 10.1002/pul2.12394. eCollection 2024 Apr.
4
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.
Compr Physiol. 2023 Jan 30;13(1):4295-4319. doi: 10.1002/cphy.c220010.
本文引用的文献
1
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
Circ Res. 2022 Apr 29;130(9):1382-1403. doi: 10.1161/CIRCRESAHA.122.319967. Epub 2022 Apr 28.
2
Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.
Circ Res. 2022 Apr 29;130(9):1423-1444. doi: 10.1161/CIRCRESAHA.121.319969. Epub 2022 Apr 28.
3
Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
Circ Res. 2022 Apr 29;130(9):1445-1465. doi: 10.1161/CIRCRESAHA.121.319990. Epub 2022 Apr 28.
4
Group 3 Pulmonary Hypertension: From Bench to Bedside.
Circ Res. 2022 Apr 29;130(9):1404-1422. doi: 10.1161/CIRCRESAHA.121.319970. Epub 2022 Apr 28.
5
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
Circ Res. 2022 Apr 29;130(9):1466-1486. doi: 10.1161/CIRCRESAHA.121.319971. Epub 2022 Apr 28.
6
New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.
Circ Res. 2022 Apr 29;130(9):1365-1381. doi: 10.1161/CIRCRESAHA.122.320084. Epub 2022 Apr 28.
7
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13.
8
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
9
Cournand and Richards: The Nobel Prize.
Ann Am Thorac Soc. 2018 Feb;15(Suppl 1):S1-S3. doi: 10.1513/AnnalsATS.201710-773KV.
10
Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1496-1499. doi: 10.1164/rccm.201712-2405LE.
Zotero 插件